166 related articles for article (PubMed ID: 34393224)
1. [Risk factors of renal sinus invasion in clinical T1 renal cell carcinoma patients undergoing nephrectomy].
Sun ZH; Huang XJ; Dong JH; Liu Z; Yan Y; Liu C; Ma LL
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 53(4):659-664. PubMed ID: 34393224
[TBL] [Abstract][Full Text] [Related]
2. Outcomes and predictors of clinical T1 to pathological T3a tumor up-staging after robotic partial nephrectomy: a multi-institutional analysis.
Gorin MA; Ball MW; Pierorazio PM; Tanagho YS; Bhayani SB; Kaouk JH; Rogers CG; Stifelman MD; Khalifeh A; Kumar R; Sivarajan G; Allaf ME
J Urol; 2013 Nov; 190(5):1907-11. PubMed ID: 23764083
[TBL] [Abstract][Full Text] [Related]
3. Perioperative morbidity, oncological outcomes and predictors of pT3a upstaging for patients undergoing partial nephrectomy for cT1 tumors.
Mouracade P; Kara O; Dagenais J; Maurice MJ; Nelson RJ; Malkoc E; Kaouk JH
World J Urol; 2017 Sep; 35(9):1425-1433. PubMed ID: 28197727
[TBL] [Abstract][Full Text] [Related]
4. ctDNA predicts clinical T1a to pathological T3a upstaging after partial nephrectomy.
Park JS; Kim H; Jang WS; Kim J; Ham WS; Lee ST
Cancer Sci; 2024 May; 115(5):1680-1687. PubMed ID: 38475661
[TBL] [Abstract][Full Text] [Related]
5. The preoperative predictive factors for pathological T3a upstaging and positive surgical margin of clinical T1 renal cell carcinoma.
Çil G; Yilmaz M; Sahin Y; Ulus I; Canıtez IO; Kandıralı IE
Actas Urol Esp (Engl Ed); 2024 May; 48(4):311-318. PubMed ID: 38369290
[TBL] [Abstract][Full Text] [Related]
6. Predictive Factors for Achieving Superior Pentafecta Outcomes Following Robot-Assisted Partial Nephrectomy in Patients with Localized Renal Cell Carcinoma.
Kang M; Gong IH; Park HJ; Sung HH; Jeon HG; Jeong BC; Jeon SS; Lee HM; Choi HY; Il Seo S
J Endourol; 2017 Dec; 31(12):1231-1236. PubMed ID: 29048228
[TBL] [Abstract][Full Text] [Related]
7. Cryoablation versus Partial Nephrectomy for Clinical T1b Renal Tumors: A Matched Group Comparative Analysis.
Caputo PA; Zargar H; Ramirez D; Andrade HS; Akca O; Gao T; Kaouk JH
Eur Urol; 2017 Jan; 71(1):111-117. PubMed ID: 27568064
[TBL] [Abstract][Full Text] [Related]
8. Renal volume matters: Assessing the association between excisional volume loss and renal function after partial nephrectomy.
Lai GS; Hung SC; Chang LW; Wang SS; Li JR; Chen CS; Yang CK; Cheng CL; Ou YC; Ho HC; Chiu KY
Asian J Surg; 2020 Jan; 43(1):257-264. PubMed ID: 31324510
[TBL] [Abstract][Full Text] [Related]
9. Upstaging to pT3a in Patients Undergoing Partial or Radical Nephrectomy for cT1 Renal Tumors: A Systematic Review and Meta-analysis of Outcomes and Predictive Factors.
Veccia A; Falagario U; Martini A; Marchioni M; Antonelli A; Simeone C; Cormio L; Capitanio U; Mir MC; Derweesh I; Van Poppel H; Porpiglia F; Autorino R
Eur Urol Focus; 2021 May; 7(3):574-581. PubMed ID: 32571744
[TBL] [Abstract][Full Text] [Related]
10. Predictive factors and oncological outcomes of pathological T3a upstaging in patients with clinical T1 renal cell carcinoma undergoing partial nephrectomy.
Ishiyama R; Omae K; Kondo T; Iizuka J; Yoshida K; Fukuda H; Tachibana H; Ishihara H; Kobayashi H; Takagi T
Jpn J Clin Oncol; 2024 Feb; 54(2):160-166. PubMed ID: 37840320
[TBL] [Abstract][Full Text] [Related]
11. Outcomes and predictors of clinical T1 renal mass (cT1) upstaged to pathological T3a (pT3a) after partial nephrectomy: A single-center experience.
Pathak N; Ganpule A; Patel D; Singh A; Shete N; Sabnis R; Desai M
Int J Urol; 2024 Mar; 31(3):252-257. PubMed ID: 38124339
[TBL] [Abstract][Full Text] [Related]
12. cT1a Renal Masses Less Than 2 versus 2 cm or Greater Managed by Robotic Partial Nephrectomy: A Propensity Score Matched Comparison of Perioperative Outcomes.
Bertolo R; Garisto J; Dagenais J; Sagalovich D; Agudelo J; Stein R; Fareed K; Gao T; Fergany A; Kaouk J
J Urol; 2019 Jan; 201(1):56-61. PubMed ID: 30100402
[TBL] [Abstract][Full Text] [Related]
13. Hilar location is an independent prognostic factor for recurrence in T1 renal cell carcinoma after nephrectomy.
Shim M; Song C; Park S; Kim A; Choi SK; Kim CS; Ahn H
Ann Surg Oncol; 2015 Jan; 22(1):344-50. PubMed ID: 25323469
[TBL] [Abstract][Full Text] [Related]
14. R.E.N.A.L. nephrometry score in clinical stage T1 renal mass: Ramathibodi hospital experience.
Prasit S; Sirisreetreerux P; Sangkum P; Kijvikai K; Viseshsindh W; Kongchareonsombat W; Leenanupunth C; Kochakarn W
J Med Assoc Thai; 2015 Feb; 98(2):181-7. PubMed ID: 25842799
[TBL] [Abstract][Full Text] [Related]
15. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies.
Mir MC; Derweesh I; Porpiglia F; Zargar H; Mottrie A; Autorino R
Eur Urol; 2017 Apr; 71(4):606-617. PubMed ID: 27614693
[TBL] [Abstract][Full Text] [Related]
16. Similar functional outcomes after partial nephrectomy for clinical T1b and T1a renal cell carcinoma.
Iizuka J; Kondo T; Hashimoto Y; Kobayashi H; Ikezawa E; Takagi T; Omae K; Tanabe K
Int J Urol; 2012 Nov; 19(11):980-6. PubMed ID: 22735049
[TBL] [Abstract][Full Text] [Related]
17. Pathological T3a Upstaging of Clinical T1 Renal Cell Carcinoma: Outcomes According to Surgical Technique and Predictors of Upstaging.
Jeong SH; Kim JK; Park J; Jeon HJ; Yoon MY; Jeong CW; Ku JH; Kim HH; Kwak C
PLoS One; 2016; 11(11):e0166183. PubMed ID: 27861519
[TBL] [Abstract][Full Text] [Related]
18. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
[TBL] [Abstract][Full Text] [Related]
19. Renal tumour anatomical characteristics and functional outcome after partial nephrectomy.
Nisen H; Heimonen P; Kenttä L; Visapää H; Nisen J; Taari K
Scand J Urol; 2015 Jun; 49(3):193-9. PubMed ID: 25385687
[TBL] [Abstract][Full Text] [Related]
20. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
Andrews JR; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2019 Aug; 76(2):244-251. PubMed ID: 31060824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
